Cheezheng Tibetan Medicine updates on share repurchase program

Tibet Cheezheng Tibetan Medicine Co., Ltd. initiated a share repurchase program on February 27, 2025, with an approved budget of not less than 90,000,000 yuan and not exceeding 160,000,000 yuan. The maximum repurchase price was initially set at 31.65 yuan per share. Following the 2024 annual equity distribution, this maximum price was adjusted to 31.27 yuan per share on July 10, 2025. A subsequent adjustment on September 22, 2025, after the 2025 semi-annual equity distribution, lowered the maximum price to 31.05 yuan per share.

As of September 30, 2025, the company has repurchased 2,673,910 shares through a dedicated securities account via centralized bidding, representing 0.47% of its total share capital. The highest price paid was 23.00 yuan per share, and the lowest was 20.31 yuan per share, totaling 58,923,491.93 yuan (excluding transaction fees). These repurchases were funded by the company’s own capital and remained below the revised maximum price limits.

Additionally, on June 4, 2025, 581,460 repurchased A-shares were transferred from the dedicated account to the 2024 Employee Stock Ownership Plan (first phase). Consequently, the remaining shares in the dedicated repurchase account as of September 30, 2025, stood at 2,092,450 shares. The company plans to continue the repurchase within the approved period, adhering to relevant regulations.